Oxymed

Oxymed contains a fourth generation fluoroquinolone antibiotic (moxifloxacin), inhibits DNA gyrase and topoisomerase IV, which carry out DNA replication, recombination and repair in the bacterial cell.
Composition: active ingredient:

• Moxifloxacin hydrochloride USP is equivalent to moxifloxacin 0.5% w/v;
• Sterile aqueous base qs.

for the treatment of inflammatory diseases of the anterior part of the eye, which were caused by microorganisms sensitive to moxifloxacin:

• Conjunctivitis;
• Corneal ulcers;
• Keratitis;
• Blepharitis;
• Dacryocystitis;
• Meibomita;
• For the prevention and treatment of bacterial eye inflammations resulting from eye injuries or after eye surgery.

Directions for use and dosage: The drug is intended only for local use in ophthalmic practice. Adults (including elderly patients over 65 years old) are prescribed 1 drop 3 times a day into the affected eye. Improvement occurs after 5 days of therapy, but treatment should be continued for another 2-3 days. If there is no therapeutic effect after 5 days of therapy, it is recommended to reconsider the diagnosis and choice of treatment tactics. The duration of the course of therapy depends on the severity of the patient’s condition, clinical and bacteriological characteristics of the infectious process.

Children do not require dose adjustment. In patients with hepatic and renal insufficiency, no dose adjustment is required. Impact on the ability to drive vehicles and machinery: As with instillations of other drugs, temporary blurred vision is possible after using the drug. Until clarity of visual perception is restored, it is not recommended to drive a car or use other machinery.

Pregnancy and lactation: The use of the drug during pregnancy and lactation is possible when the expected therapeutic effect exceeds the potential risk to the fetus and child. It may pass into breast milk in some quantities, so use of the drug during lactation is not recommended.